4//SEC Filing
KNOBELMAN DEBORAH 4
Accession 0001854270-24-000013
CIK 0001854270other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:24 PM ET
Size
7.7 KB
Accession
0001854270-24-000013
Insider Transaction Report
Form 4
KNOBELMAN DEBORAH
Chief Financial Officer
Transactions
- Award
Common Stock
2024-02-01+101,000→ 131,000 total - Award
Stock Option (Right to Buy)
2024-02-01+152,000→ 152,000 totalExercise: $0.46Exp: 2034-01-31→ Common Stock (152,000 underlying)
Footnotes (2)
- [F1]The shares reported in this transaction represent restricted stock units ("RSUs") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award vest in three substantially equal annual installments over three years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date.
- [F2]The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date.
Documents
Issuer
Senti Biosciences, Inc.
CIK 0001854270
Entity typeother
Related Parties
1- filerCIK 0001931509
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:24 PM ET
- Size
- 7.7 KB